Filter Search


Healthcare and Medical


Location Summary Deadline
Germany Conclusion Of A Non-exclusive Discount Agreement Pursuant To Section 130a Paragraph 8 Sgb V For The Active Ingredient Cinacalcet (excl. Strength 30mg, 60mg, 90mg In Standard Size N3, Atc H05bx01 For D. Z. 01.11.2431.10.26 2026-09-05
Germany Open House Drug Discount Agreements Rasagiline, Atc N04bd02 2026-09-05
Germany Open House Drug Rebate Agreements Etanercept, Atc L04ab01 2026-09-05
Germany Open House Drug Rebate Agreements Sarilumab, Atc L04ac14 2026-09-05
Germany Open House Drug Discount Agreements Piribedil, Atc N04bc08 2026-09-05
Germany Open House Drug Rebate Agreements Sorafenib, Atc L01ex02 2026-09-05
Germany Conclusion Of A Non-exclusive Discount Agreement Pursuant To Section 130a Para. 8 Sgb V For The Active Allergen Extract Of Various Origins (subcutaneous Injections; V01aa02, V01aa03, V01aa05), For The Period 01.11.2024 31.10.2026 2026-09-05
Germany Open Framework Agreement On Drug Discounts Pursuant To Section 130a Para. 8 Sgb V With The Possibility Of Joining At Any Time, So-called Approval Model 202409 2026-09-05
Germany Conclusion Of A Non-exclusive Discount Agreement Pursuant To Section 130a Para. 8 Sgb V For Medicinal Products Containing The Active Ingredient Estriol (atc Code 2026-09-27
Germany Conclusion Of A Non-exclusive Discount Agreement Pursuant To Section 130a Para. 8 Sgb V For Medicinal Products Containing The Active Ingredient Vildagliptin (atc Code 2026-09-27
Whats app